KHCC launches region’s first tissue bank for personalised cancer research

  
Prof Dr ahmoud Sarhan, Director General of King Hussein Cancer Center (KHCC), announced in November last year the establishment of a tissue bio bank (KHCCBIO) in Jordan. Sponsored partially by the European Union, the bio bank will be the first of its kind in Jordan and the region. It is expected to start operating this year.

Prof Sarhan said the project was important to pursue the global trend in conducting research on cancer and in finding effective treatment methods by implementing the personalised medicine approach.

He explained that personalised medicine depends on the utilisation of an individualised treatment protocol for each patient, depending on their genetic data. This can enable treatment to be targeted at the cancer without affecting healthy tissue.

KHCCBIO will be able to support studies designed to explore the environmental and genetic factors that influence the occurrence and development of cancer and its patterns of spread, and linking these factors with people’s habits and behaviours, such as patterns of smoking, diet, physical exercise and other aspects of life which may influence the incidence of cancer.

Dr Maher Sughayer, the Director of Department of Pathology and Laboratory Medicine at KHCC and the Coordinator of this project, said that KHCC, in view of its distinguished position among cancer centres in the world, has won the confidence of the European Union as the coordinator of a grant estimated around Euro 550,000, which is part of the total cost of the project of establishing KHCCBIO.

This grant will enable KHCC-EU partners from Ireland and Switzerland to contribute to the development of policies and procedures for the establishment of KHCCBIO as well as the training of pathologists and laboratory technologists on how to collect and store cancer tissue extracted from patients according to ISO quality international standards to be further used in personalised medicine research.

Dr Sughayer pointed out that the analysis and study of such samples would support cancer diagnosis and give a clearer picture of the disease stages and its progression. It is envisioned that this tissue bank will be a gateway to collaborate with other clinical and research centres around the world.

Dr Lina Souan, the head of the clinical Immunology Laboratory at King Hussein Cancer Center, explained that the bio bank would take surplus-cancer tissue collected from consenting patients, process it and store it according ISO-accredited quality protocols. Thereafter, this tissue will be used in clinical research studies aimed at improving the application of personalised medicine without exposing the patient’s confidential information.



New Egyptian minister of health

Dr Fouad El Nawawi has been appointed the new Minister of Health and Population in Egypt, following the elections in the country in December. He is professor of internal medicine at Cairo University and the former director of the Qasr Al-Aini hospital. According to the Egyptian Gazette he said on his first day in office that there was an urgent need to treat people injured during the protests since the outbreak of the revolution last January. He said extra budget would be allocated to this.

Dr el-Nawawi said that the ministry’s initial priorities would be to look after handicapped people and those who had been permanently disabled during the clashes in Tahrir Square. According to the newspaper report, he added that training courses would be organised for doctors treating eye, chest, head and heart injuries and that, if necessary, foreign specialists would also be used to treat these injuries,.

He pointed out that another of the ministry’s priorities would be to provide healthcare for children about to start school.



American Hospital Dubai appointsAmerican Hospital Dubai starts using medical oncologist

American Hospital Dubai has appointed Dr Khan as Medical Oncologist in the hospital’s Cancer Care Center. The appointment comes as the Hospital continues to develop the center as a regional center of excellence and prepares to launch a new and comprehensive range of diagnostic and treatment services for cancer patients.

Dr Faraz A Khan is American Board Certified in Internal Medicine (2002), Medical Oncology (2005), and Hematology (2005), and joined the hospital from Prince Edward Island (PEI), Canada, where he was Medical Oncologist, and Hematologist, at the PEI Cancer Treatment Center in Charlottetown in addition to other medical posts.



Al Zahra Hospital first with Freedom Knee implant

Al Zahra Hospital in Sharjah in October last year performed a unique knee implant surgery, believed to be the first-of-its-kind in the UAE. A total knee system called the Freedom Knee was implanted in a 48- year-old female patient. The knee system offers a high degree of flexion making it good for praying, kneeling and sitting on the floor. And it is robust enough to be used in a number of sporting activities.

Commenting on the surgery, Dr Deepak Bhatia, Senior Orthopaedic Consultant, Al Zahra Hospital, said: “This has been a breakthrough surgery for us, and we take pride in becoming the first hospital in the region to use a knee implant of this kind. This advanced knee replacement system requires minimum bone cutting, which is a major benefit for the patients, as our population is known to have a high incidence of osteoporosis and less bone stock.

“Moreover, this knee provides the required high-flexion to allow our patients to perform their daily activities with complete freedom. Patients have also been able to carry out sporting activities such as swimming, golfing, tennis, and hill walking after undergoing this surgery. The availability and multiple choices in size enable this operation to be carried out both in large male and small female patients without any compromise. This is extremely important, as women in our region tend to have smaller bones compared to their Western counterparts.”

Dr Bhatia added that the new implant shortens the hospitalisation to around three days and is also suited for younger patients requiring a knee replacement surgery.



Oman steps into the medical tourism business

A private sector company will develop a medical tourism complex in Salalah, Oman in an effort to boost tourism to the country on the back of a fast growing international medical tourism market.

Dr Abdullah Al-Joaib, the founder and President of AMG and President of Al- Joaib Holding, with the Oman authorities, signed late last year, the first land acquisition agreement of the Integrated Medical Tourism Complex in Salalah.

AMG will develop a Medical City with 530-bed Tertiary Care Hospital integrated with the regional Multispecialty Organ Transplant and Rehabilitation Centre, a diagnostic and medical prevention centre, healthcare resort and a healthcare education complex.

Dr Abdullah said that this regional medical tourism project will be developed initially on 500,000 sq m of land with a government-approved expansion plan to 800,000 sq m. The site is approximately 15 minutes’ drive from the Salalah International airport which is undergoing expansion due to be completed in 2014.

This AMG project is in line with a 5- year tourism development plan of the Ministry of Tourism and has the full backing of the Oman Government, including the Ministry of Health.

According to a statement by AMG, this integrated medical tourism project will be supported by the international growth of medical tourism, which is predicted to be worth more than US$100bn this year.

Dr Abdullah said: “The strategic vision of the project is to create a high-quality, sustainable, healthcare-led, mixed-use development that functions as a vibrant, sustainable and self-sufficient community and place Oman as a preferred destination for medical tourism on the globe.”



Dubai’s new children’s hospital construction enters second phase

The Dubai Health Authority (DHA) announced the start of the second phase of construction of the Al Jalila Children’s Specialty Hospital. The hospital will offer the full spectrum of healthcare for children – from newborns to 16-year-olds – and will have several centres of excellence dedicated to cancer care, cardiology, neurology and mental health, among other specialties.

The hospital is being developed on grounds within the Al Wasl Hospital campus – Dubai’s current paediatric hospital. The 4-storey, 200-bed facility is expected to be complete in about two years. The hospital will have 40 intensive care units, six dialysis facilities, 20 healing centres, 12 training rooms, eight operating theatres, 30 clinical and non-clinical departments, and a multipurpose activities room for children. Other key facilities will include radiology, nuclear medicine, an advanced clinical laboratory, an emergency department, a neonatal intensive care unit, a burn unit, endoscopy facilities, rehabilitation and pharmacy, among others.

Commenting on the development, Qadhi Saeed Al Murooshid, the Director- General of DHA, said: “Al Jalila Children’s Speciality Hospital will redefine paediatric care in the UAE and the wider region. The hospital is the vision of His Highness Sheikh Mohammed, to provide the highest standards of care to children, covering all relevant specialities, in a warm and welcoming environment.

Our mission is to provide world-class medical practices for children, right here in Dubai, thereby adding to the convenience of parents, who are sometimes forced to travel abroad to seek critical care for their kids.”

The design of the facility focuses on sustainability with a number of innovative concepts to enhance the healing process.

The eco-friendly design and development model of the hospital has won international honours, including the Future Projects – Health Award at the World Architecture Festival in Barcelona, 2009; and the Hospital Build Award 2011 for Best Sustainable Hospital Project.

Several energy-saving initiatives are being used, including sustainable construction techniques to reduce energy use, an active façade system to reduce ambient temperature inside the hospital, and rooftop gardens that provide greater insulation.

Of the total area, nearly half has been earmarked for gardens and landscaping including a ‘healing garden’. The hospital will use recycled water for irrigation purposes.

The use of natural light, greenery and healing landscape are aimed at enhancing indoor air quality, reducing noise and creating a pleasant environment.

Khalid Al Sheikh Mubarak, Deputy Director-General of the DHA, said: “The entire operational and development aspects of Al Jalila Children’s Speciality Hospital have been developed following extensive research and visits to globally renowned paediatric facilities. We are drawing on the best expertise across the board to give all UAE residents as well as patients from the region the easiest access to world-class paediatric care.”

“The focus of the hospital, which follows a horizontal layout plan, will be to enhance the efficient and non-intrusive interaction between the patients and their parents,” he added.

“The design, architecture and décor elements aim to stimulate the participation and imagination of children through visual aids, interactive touch-surfaces, imaginative shapes, and integrating arts, music and nature as part of the overall healthcare welfare strategy.”



Jordan launches healthcare ICT task force

His Majesty King Abdullah II of the Hashemite Kingdom of Jordan and John Chambers, chairman and CEO of Cisco formally inaugurated Jordan’s first Healthcare ICT Task Force at a session, held alongside the World Economic Forum Middle East 2011 at the Dead Sea, Jordan.

A joint effort by Cisco, King Abdullah II Fund for Development (KAFD), and Jordan’s Information and Communications Technology Association (int@j), the Jordan Healthcare ICT Task Force is an open forum of Jordanian Health Information Communications Technology (ICT) companies under the umbrella of int@j. The Task Force's main objective is to advance Jordan's healthcare ICT cluster capacity and promote Jordanian healthcare ICT technologies and companies on a local, regional, and international level. Cisco's role will be to help guide, mentor, and support the Task Force’s programmes.

According to a statement by Cisco, the Task Force will aim to promote knowledge sharing and marketing for companies under the umbrella of the Jordan Healthcare ICT Task Force cluster, as well as help to accelerate the growth of Jordan's healthcare ICT companies as a forum for joint collaboration and cooperation. It will also serve as a point of reference for global and regional leaders wishing to partner with Jordan's Healthcare ICT cluster.

Task Force activities will include, amongst other initiatives, assessing Jordan's healthcare delivery system position relative to the region and globally in healthcare ICT technologies. It will also develop mentorship programs to link Jordanian companies with innovative and leading global healthcare ICT brands; and develop a forum to enable cluster companies to advance and innovate through current opportunities and future trends in Healthcare ICT Technologies globally.

- Cisco says that industry experts predict that three technology innovations are set to transform the healthcare industry:

- Cloud computing: the growth of cloud computing and the ability to deliver intelligence at scale will enable disruptive business models through healthcare exchange.

- Mobility: explosive mobile device and data growth will change healthcare delivery and drive new behaviours for clinicians and patients .

- Collaboration: collaborative technology in areas such as clinical workflow, telehealth, and knowledge sharing, will improve access to healthcare, increase the efficiency of care delivery, and make healthcare more affordable.

Mohammad Tahboub, chairman of the Information Technology Association of Jordan, Int@j, said: “The taskforce will be focused on achieving multiple objectives, including rapidly replicating the Hakeem programme nationwide and positioning Jordan as a regional hub for ICT solutions in the healthcare sector. The Task Force's main objective is to advance Jordan's healthcare ICT cluster capacity and promote Jordanian healthcare ICT technologies and companies on a local, regional, and international level.”

The Hakeem programme, which has been run as a pilot project for the past two years, is designed to create a database of patients’ medical histories across the Kingdom, covering all state-run hospitals, the Royal Medical Services, King Hussein Cancer Center and the public universities’ educational hospitals. 



Dubai’s Canadian Specialist Hospital awarded JCI accreditation

Canadian Specialist Hospital (CSH), one of the largest private hospitals in Dubai catering to the tertiary healthcare needs of the Middle East, has been awarded the prestigious Joint Commission International (JCI) accreditation, the leading industry benchmark for measuring the delivery of quality healthcare.

“This accreditation demonstrates our commitment to improving quality, ensuring a safe environment and reducing risks to patients and staff. The management and staff of Canadian Specialist Hospital are fully committed to providing quality, standards-based healthcare in the Middle East, while ensuring continuous improvement is integral to the operation of the facility. The Joint Commission standards are the driving force behind our practices and processes,” said Dr Hayder Al Zubaidy, CEO of Canadian Hospital.

Canadian Specialist Hospitals (Deira and Bur Dubai) are two of the largest private hospitals in Dubai and the institution of choice for referrals from small and medium-sized medical centres that lack certain specialised diagnostic and treatment facilities.



KFSH Heart Centre installs integrated cardiovascular information system

LUMEDX Corporation, a provider of vendor-neutral, integrated cardiovascular information and imaging systems (CVIS), says that the King Faisal Specialty Hospital and Research Centre has deployed a comprehensive LUMEDX CVIS in its Heart Centre. The new solution connects cardiovascular patient data to the hospital electronic health record (EHR), thus enabling complete, longitudinal patient records accessible by physicians at any point in the continuum of care.

Majid Al Fayyadh, MD, Pediatric Electrophysiology section head and project executive of the Heart Centre’s informatics group, Heartnet, said: “King Faisal Specialty Hospital is committed to automating and becoming as paperless as possible. Because enterprise systems do not give us all the data and workflow we require in cardiology, we sought a solution that could satisfy our needs and yet still meet the requirements of the hospital.

“Fortunately, through a series of multiple interfaces at multiples levels, and through much hard work by us, by LUMEDX and also by Al-Faisaliah Medical Systems, we have been able to achieve full integration. This means that from the moment the patient walks in, all patient information-- the ADT data, the order, the procedural data including images, the finalized report and billing data--flows seamlessly from point to point.”

Deployed in four stages, the King Faisal CVIS solution was designed to correspond to the Heart Centre sections’ unique workflows. Components include:

- Apollo clinical data repository
- Clinical interfaces, including:
- MUSE (ECG, Stress and Holter, including interfaced-triggered reporting)
- Philips Xcelera Images Integration
- Orders add-on to ADT
- Registration to Siemens CathCor
- Patient reporting for Cath, Pediatric Cath, Surgery, and EP/Implantables



AUBMC opts for Philips devices for modernised radiology dept

The American University of Beirut Medical Center (AUBMC) has opted to use Philips Healthcare to modernize their radiology department, which will see the installation of a range of radiology devices including MRI, CT and PET-CT systems.

The modernization initiative is part of AUBMC’s 2020 Vision to be the leading academic medical centre in Lebanon and the region by providing excellence in patient-centred care, outstanding education and innovative research, according to Dr Mohammed Sayegh, Dean of the Faculty of Medicine at AUBMC.

In a statement, Philips said the common goal of AUBMC and Philips is to provide unique patient experience with minimised radiation dose levels and maximum patient comfort, without compromising on the diagnostic outcome.

AUBMC will be installing the Philips MRI Ingenia 3.0T, which is the first-of-itskind digital broadband Magnetic Resonance Imaging (MRI) device. The medical facility will also install the Philips Brilliance iCT, which along with the iDose dose reduction program is expected to ensure that patients receive significantly reduced radiation dose when being scanned.

Jens Gustmann, General Manager of Philips in the Levant, said: “AUBMC is an ideal partner for Philips, not only because of their impressive history, but the vision they have when it comes to providing first class healthcare today, and in the future. It is also an opportunity for both parties to create synergies in the field of clinical science and education.”



American Hospital Dubai starts using RapidArc linear accelerator

The American Hospital Dubai has launched its new Radiation Therapy (RT) unit at the Cancer Care Center at the Dubai campus, with a team of six specialist staff. Based on the most advanced RT technology available – the RapidArc linear accelerator – the new radiation oncology service is designed for patients requiring curative and palliative radiotherapy as part of their cancer treatment.

With the addition of the new radiotherapy capabilities, the hospital’s Cancer Care Center now offers a comprehensive range of advanced care, diagnostics and treatment options for all types of cancer.

The Cancer Care Center uses ‘RapidArc’ radiotherapy, an advanced technology that improves radiation dose conformity and significantly shortens treatment times.

Dr Salim Chaib Rassou, a radiation oncologist at the American Hospital Dubai, said: “RT is a fundamentally important part of the Cancer Care Center and we are delighted that we have access to the most advanced technology available as well as a team of highly experienced oncology specialists. The American Hospital Dubai can now provide comprehensive cancer care, medical imaging and treatment options, including chemotherapy and surgery in addition to radiotherapy and we are proud to announce that we are the first radiotherapy facility in the UAE to start this new mode of radiotherapy delivery with ‘RapidArc’.”

Thomas Murray, CEO of the American Hospital Dubai, said: “Introducing advanced RT is a major step forward for us in developing a regional center of excellence in cancer care. The RapidArc technology is truly state-of-the-art and will make a significant difference in the quality and effectiveness of treatment for cancer patients in the community. We have had a lot of interest in the new unit and the very exprienced team is already treating patients. Our ultimate objective is to provide effective curative and palliative radiotherapy treatment and care to patients in a compassionate, safe and modern environment.”



Long-term acute care facility opened in Abu Dhabi

The ProVita International Medical Center in Abu Dhabi was officially opened in October last year. The facility provides round-the-clock, long-term care for acute, ventilator dependent patients in a nonhospital setting.

The establishment of the medical centre marks the first investment in the region by TVM Capital MENA, a private equity firm focusing on investments in health care in the Middle East and North Africa (MENA).

In a statement, TVM Capital MENA said the genesis of the clinic, and more specifically the collaboration with the founder of ProVita clinics in Germany, Christina Shawky-Boehme, is consistent with the TVM Capital MENA strategy of involving leading operators from more fully developed healthcare markets such as in Europe or North America to provide unique and specialised healthcare services in the Middle East, directly catering to the growing local demand.

Dr Helmut M. Schuehsler, Chairman & CEO of TVM Capital MENA, said: “We are proud of the work that ProVita has been able to do and the difference it has made to the quality of life of severely ill and ventilator dependent patients in Abu Dhabi. The facility is a first for the region and a testament to the growth and development of the local healthcare industry. The demand for long-term care remains high and we hope to expand the ProVita offering throughout the region.’’



Sheikh Khalifa Specialist Hospital chooses Berchtold lighting devices



The Sheikh Khalifa Specialist Hospital in Ras Al Khaimah, United Arab Emirates, has commissioned Berchtold to deliver 108 ceiling mounts, 130 OR and examination lights, and 13 mobile OR-tables with accessories. This is the largest single order Berchtold has received in the past 10 years, according to a statement by Berchtold.

The 248-bed Sheikh Khalifa Specialist Hospital in Ras Al Khaimah, is expected to be the most state-of-the-art medical facility in the Emirate and was due to be completed late 2011, early 2012. It has been designed to the highest tertiary care standards combining advanced medical technology, international design and healthcare planning solutions. The sixstory structure will incorporate specialties such as oncology, cardiology, a trauma centre, and an emergency department. Patient privacy and healing are emphasised through the project’s hospitality- like design including a genial network of calming lounges, sun-filled atriums, and other supportive environments throughout the facility.

Berchtold will provide their Chromophare F 300 and Chromophare D 300 therapy and examination lights. They are the latest generation of high-performance LEDs, providing optimal lighting almost without reflections and shadows, ideal colour reproduction of patient tissue, and low power consumption.

A Berchtold spokesperson explained that, depending on the need, the examination lights can be mounted on ceilings, walls, or mobile floor stands. For the operating rooms, the hospital will receive various halogen lights with a light intensity from 80,000 to 160,000 lux. Both the Chromophare D 300 examination light and the surgical lights are equipped with “BRITe Technology” (Berchtold Reflective Illumination Technology). This reflects unwanted warm infrared radiation precisely back onto the filament. The scope of the contract also includes various LED lights.

The deal also includes the installation of the Operon D 760 and D 850 type mobile operating tables.



American Hospital Dubai launches Transitional Care Unit

The American Hospital Dubai has extended its patient services with the launch of a new Transitional Care Unit (TCU) to offer a unique alternative for families seeking the highest level of specialist, multidisciplinary care for their loved ones. The TCU unit provides an option when home care is no longer sustainable or when both home carers and patients need a respite period. It is believed to be the first private healthcare unit of its kind in the UAE.

The TCU at the American Hospital Dubai puts an emphasis on the physical and mental wellbeing of patients, and incorporates the latest technology and facilities used in providing state of the art long term care for patients, in an environment and surroundings that provide comfort and reassurance for senior patients and their families, in spacious private rooms and suites with attractive views.

Dr Senthil Meenrajan Consultant Geriatrics / Internal Medicine at American Hospital Dubai, comments: “When older loved ones (and patients of any age with a debilitating condition) reach the stage that they need the kind of long term care beyond the means of care givers at home, the family wants to be sure that they are in the hands of a specialist team of professional care providers, operating to the highest standard of healthcare delivery in an accredited institution. We are very pleased to add this important new unit to our expanding Dubai campus and believe it is the first of its kind in the UAE. The new TCU unit will provide sustained, consistently high levels of specialist expertise in one of the most demanding areas of patient care, and in a very high quality environment.”



Hicom partners with CCMENA to expand ME operations

UK-based Hicom, a healthcare IT solutions and services specialist, has expanded its international operations by partnering with CCMENA (Converged Communications Middle East and North Africa) – a leading supplier of IT products and services operating throughout the Middle East.

The partnership will see Hicom extend its existing presence within the region, providing high quality hospital information systems and clinical care management solutions to Middle East healthcare providers.

Jason Snelling, Healthcare Product Manager at CCMENA, said Hicom’s software is state-of-the-art and is particularly appealing due to the flexibility and customisation that can be applied to the product to fit each customer’s requirements.

“This level of tailoring isn’t available with the other products currently on the market in the Middle East, and so provides us with a great USP within the industry,” he said.

John Sanderson, Director at Hicom, said: “We are delighted to partner with CCMENA and look forward to the great opportunities it will bring to both companies. Together we can provide to the region, a comprehensive range of healthcare technology services, including infrastructure design & implementation, consultancy & procurement, software design & development, software integration, system hosting and project management.

“We have a number of successful implementations already within the UAE including the the Imperial College London Diabetes Centres in Abu Dhabi and Al Ain, the Rashid Centre for Diabetes and Research in Ajman and Moorfields Eye Hospital in Dubai, but CCMENA’s local knowledge, experience and contacts will be a huge asset to us and will help us provide the high quality healthcare solutions that the region requires.”



UAE doctors call for more osteoporosis screening

UAE doctors are urging for an increase in screening for osteoporosis in the Gulf, saying that most cases are preventable and treatable.

The call follows the first Middle East and Africa Osteoporosis Meeting that took place in Dubai in October last year. The meeting forms part of the International Osteoporosis Federation (IOF) regional programme which gathers international rheumatology and osteoporosis experts to discuss the prevention, diagnosis and treatment of osteoporosis.

Dr Tarek Tawil, Chief of Staff of Spine and Joint Units, Elaj Medical Centres, GCC and Middle East North Africa, said: “The number one way to prevent osteoporosis is to ensure appropriate screening is conducted on those at risk. Unlike other ailments, osteoporosis is a silent disease and unfortunately in cases where a patient is undiagnosed, they don’t realise they have it until they have a fracture.

“In the UAE especially, we are seeing younger and younger women diagnosed with the disease due to the specific lifestyle issues related to living here, such as bad diet and a severe lack of vitamin D due to reduced sun exposure. It’s crucial that the community is aware of the importance of screening in preventing and treating osteoporosis,” Dr Tawil added.

Earlier this year a local audit revealed the UAE has a comparatively low number of specialist screening machines, used to detect bone density, which are under used. The IOF recommends one Dual- Energy X-ray Absorptiometry (DEXA) machine per 10,000 head of population and the UAE audit found that the country has one machine per 100,000 of which many are under-utilised, suggesting that many with osteoporosis, which affects one in three women in a lifetime, are going undetected.



Gulf COAST study to track incidence of ACS in the region

Leading cardiologists from the UAE, Kuwait, Bahrain and Oman met in Dubai in November last year to decide on plans and timelines for the launch of the “Gulf loCals with acute CorOnAry Syndrome evenTs” Registry, or Gulf COAST Registry. Gulf COAST, which is set to start in January this year, will track and assess the incidence, risk factors and treatment of patients with acute coronary syndrome (ACS) across four GCC countries. This is the first study of its kind to focus on Gulf citizens.

In a collaborative effort, the study will track for up to one year 4,000 Gulf citizens who are admitted with a diagnosis of ACS to any of 35 hospitals in the region. The meeting marked a significant milestone in a process that began in Dubai in June last year, with the signing of a Memorandum of Understanding for coronary research by AstraZeneca Gulf.

“Heart disease is the number one killer, both in the region and in the UAE, accounting for 25 to 30% of UAE deaths,” said Dr Fahad Omar Baslaib, President of the Emirates Cardiac Society and Head of the Cardiology Department at Rashid Hospital. “This study is an important step for both our country and our region. Heart disease disproportionately affects our region, with the average age of acute coronary syndrome patients across the Middle East a decade younger compared with the West, and this study will help us understand why.”

The objectives of Gulf COAST are to understand the incidence of ACS and regional risk factors and outcomes, to benchmark against current accepted practices and guidelines, and to establish a network of collaborators in this research. Gulf COAST will cover the patient from the time they arrive at the hospital, through discharge and beyond, up to one year.

Gulf COAST is supervised by a 17- member study Steering Committee of senior cardiologists and leading experts from the four countries and an international scholar from the United States.


 

                                                                                                   
                                                                        Copyright © 2011 MiddleEastHealthMag.com. All Rights Reserved.